UK markets close in 4 hours 35 minutes
  • FTSE 100

    +19.70 (+0.28%)
  • FTSE 250

    +23.33 (+0.10%)
  • AIM

    -0.31 (-0.02%)

    -0.0017 (-0.15%)

    -0.0031 (-0.22%)

    +249.55 (+0.89%)
  • CMC Crypto 200

    +32.50 (+3.35%)
  • S&P 500

    +7.71 (+0.18%)
  • DOW

    -85.85 (-0.25%)

    +0.58 (+0.82%)

    +0.30 (+0.02%)
  • NIKKEI 225

    +279.50 (+0.96%)

    -203.60 (-0.71%)
  • DAX

    +73.44 (+0.47%)
  • CAC 40

    +25.69 (+0.39%)

Global Microbiome Sequencing Services Market (2021 to 2026) - by Technology, Application, Research Type, Laboratory Type, End-users and Geography

·7-min read

Dublin, May 17, 2021 (GLOBE NEWSWIRE) -- The "Global Microbiome Sequencing Services Market (2021-2026) by Technology, Application, Research Type, Laboratory Type, End-users, Geography and the Impact of COVID-19 with Ansoff Analysis, Infogence Competitive Quadrant" report has been added to's offering.

The Global Microbe Sequencing Services Market is estimated to be USD 1.2 Bn in 2021 and is expected to reach USD 2.73 Bn by 2026, growing at a CAGR of 17.8%.

Microbiomes are a group of micro-organisms living on a human body. They live on the skin, eyes, saliva, mouth, and the gastrointestinal tract. The human microbiome contains thousands of bacterial species/microbes in diverse communities, along with their genes, proteins, and metabolites. An imbalance of these microbes can lead to life-threatening diseases. The study of Microbiome sequencing and its techniques relates to the study of the microbial composition of the human gut and to understand the resulting impact on health and disease development.

Microbiome sequencing is usually done to understand this microflora residing on the human body and further study human microbes and their role in related diseases. This study can also be helpful while analyzing the patient's response to a particular treatment. Effective understanding and application of microbiome sequencing services would help in the commercialization of personalized medicine and diet. Hence, the market is extensively driven by research-based communities, especially in the developed economies like the US, which has the presence of NHGRI (National Human Genome Research Institute) supporting the growth of the market.

Due to advancements in technology, there has been a rise in the NGS (Next-Gen Sequencing) to generate microbiome data. Besides, techniques such as novel high-throughput sequencing and new software tools are transforming microbiome studies by providing service at high quality, speed, and high cost. Many companies are additionally concentrating on novel exome sequencing and RNA sequencing applications in niche market segments.

Specific factors that have led to the growth of this market are the rising use of microbiome in genomics, along with the reduced cost of sequencing. However, other factors such as the lack of expertise in the data analysis for the microbiomes with advanced tools shall hinder the growth of this market.

Market Dynamics


  • Increased Focus on Human Microbiome Therapy

  • Reduction in the Cost of Sequencing

  • Human Microbiome as a New Validated Target for Drug Development

  • Human Microbiome Used as an Aid for Early Disease Detection and Diagnosis

  • Increasing Demand for NGS


  • Lack of Skilled Professionals for Microbiome Sequencing Services

  • Lack of Awareness Among Physicians and Scientist about Advanced Tools for Data Analysis

  • Barriers in Proving the Causal Link Between Dysbiosis and Disease


  • Investigational New Drug (IND) Requirements for Fecal Microbiota

  • Increasing Collaborations Create Growth Opportunities

  • Increasing Research Investments and Technological Advancements

Company Profiles

Some of the companies covered in this report are Clinical Microbiomics A/S, Baseclear B.V., Metabiomics Corp., Microbiome Insights Inc., Microbiome Therapeutics, Llc., MR DNA, Merieux Nutrisciences Corporation, Ubiome, Inc., Zymo Research Corp., Second Genome, Rancho Biosciences, and others.

Competitive Quadrant

The report includes a Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Why buy this report?

  • The report offers a comprehensive evaluation of the Global Microbiome Sequencing Services Market.

  • The report includes in-depth qualitative analysis, verifiable data from authentic sources and projections about market size. The projections are calculated using proven research methodologies.

  • The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys and observation of renowned personnel in the industry.

  • The report includes in-depth market analysis using Porter's 5 force model and the Ansoff Matrix. The impact of Covid-19 on the market is also featured in the report.

  • The report also contains the competitive analysis using the Competitive Quadrant, the analyst's Proprietary competitive positioning tool.

Report Highlights:

  • A complete analysis of the market including parent industry

  • Important market dynamics and trends

  • Market segmentation

  • Historical, current, and projected size of the market based on value and volume

  • Market shares and strategies of key players

  • Recommendations to companies for strengthening their foothold in the market

Key Topics Covered:

1 Report Description
1.1 Study Objectives
1.2 Market Definition
1.3 Currency
1.4 Years Considered
1.5 Language
1.6 Key Shareholders

2 Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.2.1 Secondary Research
2.2.2 Primary Research
2.3 Market Size Estimation
2.4 Assumptions of the Study
2.5 Limitations of the Study

3 Executive Summary

4 Market Overview
4.1 Introduction
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Challenges
4.3 Trends

5 Market Analysis
5.1 Porter's Five Forces Analysis
5.2 Impact of COVID-19
5.3 Ansoff Matrix Analysis

6 Global Microbiome Sequencing Services Market, By Technology
6.1 Introduction
6.2 Sequencing By Synthesis (SBS)
6.3 Sequencing By Ligation (SBL)
6.4 Pyrosequencing
6.5 Sanger Sequencing
6.6 Shotgun Sequencing
6.7 Targeted Gene Sequencing
6.8 RNA Sequencing
6.9 Other Technologies

7 Global Microbiome Sequencing Services Market, By Products & Services
7.1 Introduction
7.2 Reagents & consumables
7.3 Instruments
7.4 Services
7.5 Analysis & data interpretation solutions

8 Global Microbiome Sequencing Services Market, By Application
8.1 Introduction
8.2 Gastrointestinal Diseases
8.3 Infectious Diseases
8.4 CNS Diseases
8.5 Oncology
8.6 Other Applications

9 Global Microbiome Sequencing Services Market, By Research Type
9.1 Introduction
9.2 Outsourced
9.3 Internal

10 Global Microbiome Sequencing Services Market, By Laboratory Type
10.1 Introduction
10.2 Wet Labs
10.3 Dry Labs

11 Global Microbiome Sequencing Services Market, By End Users
11.1 Introduction
11.2 Pharmaceutical and Biotechnology Companies
11.3 Academia/Research Institutes
11.4 Others

12 Global Microbiome Sequencing Services Market, By Geography
12.1 Introduction
12.2 North America
12.2.1 US
12.2.2 Canada
12.2.3 Mexico
12.3 South America
12.3.1 Brazil
12.3.2 Argentina
12.4 Europe
12.4.1 UK
12.4.2 France
12.4.3 Germany
12.4.4 Italy
12.4.5 Rest of Europe
12.5 Asia-Pacific
12.5.1 China
12.5.2 Japan
12.5.3 India
12.5.4 Australia
12.5.5 Rest of APAC
12.6 Middle East and Africa

13 Competitive Landscape
13.1 Competitive Quadrant
13.2 Market Share Analysis
13.3 Competitive Scenario
13.3.1 Mergers & Acquisitions
13.3.2 Agreements, Collaborations, & Partnerships
13.3.3 New Product Launches & Enhancements
13.3.4 Investments & Fundings

14 Company Profiles
14.1 Baseclear B.V.
14.2 Clinical-Microbiomics A/S
14.3 Molzym GmbH & Co. Kg
14.4 Zymo Research Corp.
14.5 Rancho Biosciences
14.6 Microbiome Therapeutics, LLC.
14.7 Microbiome Insights Inc.
14.8 Openbiome
14.9 Resphera Biosciences, LLC.
14.10 MR DNA (Molecular Research LP)
14.11 Shanghai Realbio Technology Co., Ltd
14.12 Diversigen, Inc.
14.13 Merieux Nutrisciences Corporation
14.14 Metabiomics Corp.
14.15 Second Genome
14.17 BioSpherex LLC

15 Appendix
15.1 Questionnaire

For more information about this report visit

CONTACT: CONTACT: Laura Wood, Senior Press Manager For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900